bisbenzimidazole has been researched along with Glial Cell Tumors in 2 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaur, N | 1 |
Ranjan, A | 1 |
Tiwari, V | 1 |
Aneja, R | 1 |
Tandon, V | 1 |
Yoshimura, S | 1 |
Sakai, H | 1 |
Ohguchi, K | 1 |
Nakashima, S | 1 |
Banno, Y | 1 |
Nishimura, Y | 1 |
Sakai, N | 1 |
Nozawa, Y | 1 |
2 other studies available for bisbenzimidazole and Glial Cell Tumors
Article | Year |
---|---|
DMA, a bisbenzimidazole, offers radioprotection by promoting NFκB transactivation through NIK/IKK in human glioma cells.
Topics: Bisbenzimidazole; Cell Line, Tumor; Cell Survival; Glioma; Humans; I-kappa B Kinase; NF-kappa B; NF- | 2012 |
Changes in the activity and mRNA levels of phospholipase D during ceramide-induced apoptosis in rat C6 glial cells.
Topics: ADP-Ribosylation Factors; Animals; Apoptosis; Bisbenzimidazole; Cell Survival; Ceramides; DNA Fragme | 1997 |